Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • wbb1813
    Member
    • May 2014
    • 12

    #1

    How to deal with normalized RNA seq data?

    Hi everyone !
    I have got the TCGA data about prostatic cancer,the data has been normalized.Now I want to analysis it and find some different expressed genes.
    my question is what method can I use except limma and t.test?
    Thank you !
  • mbblack
    Senior Member
    • Aug 2009
    • 245

    #2
    Starting with normalized data, you can use LIMMA, T-Tests or ANOVA. Of course, without biological replicates, you cannot do any statistical analysis of differential gene expression at all, so I'm assuming you have at least 2 biological replicates for each condition (and really, 3 should be the bare minimum acceptable for any reliable stats).
    Michael Black, Ph.D.
    ScitoVation LLC. RTP, N.C.

    Comment

    • wbb1813
      Member
      • May 2014
      • 12

      #3
      Thank you for your reply!
      The data which I got is 180 samples ,contain 141 tumor samples and 39 normal samples .I have analysis the data with LIMMA and T-Test,when I use LIMMA I choose 3 tumor and 3 normal to analysis ,I find about 80 different expressed genes(diffgenes),then I choos 10 tumor and 10 normal,I get about 2000 diffgenes ,finally I use all the tumor and normal samples ,unintelligibly,I get 10,000 diffgenes.
      I don't know why this phenomenon happen ?
      Should I do some cluster or PCA before analysis (Actually,I have done these method ,but cluster and PCA didn't work well,I can't cluster all the 180 sample perfectly),is there any other method to do this work?
      I'm a junior ,thank you for your help !

      Comment

      • mbblack
        Senior Member
        • Aug 2009
        • 245

        #4
        Any time that you increase the number of replicates, you will likely detect more significant results. That is the whole point of replication. The more replicates, the more precise is your estimate of the population mean and variance, and hence the smaller the change you can now detect as significant (i.e. unlikely to be observed by chance). Statistical significance is all about your ability to estimate population mean and variance, and the more replicates you have, the better your estimates of those parameters.

        This is the very reason why biological replicates are so important in detecting differential gene expression. The more replicates, the greater your ability to detect ever more subtle changes in gene expression.

        Unless you have some rational reason to reject a sample, you should always use all of your biological replicates when testing for differential gene expression - you have the most power to discriminate differences then.

        When selecting differentially expressed genes though, you should NOT rely purely on statistical significance. Many published studies have clearly shown that you will get your most reliable results if you simultaneously use both a statistical threshold (e.g. FDR<0.05 is common), AND a magnitude threshold (e.g. absolute value of estimated fold change >1.5, or >2.0 are common cutoffs).

        Genes selected by simultaneously applying a statistical, AND a magnitude threshold are the most likely to validate via an independent method such as RT-qPCR.
        Michael Black, Ph.D.
        ScitoVation LLC. RTP, N.C.

        Comment

        • dpryan
          Devon Ryan
          • Jul 2011
          • 3478

          #5
          The more samples you use, the more power you have. That's a completely expected result. With enough samples you'd likely find almost everything to be at least slightly different between the two samples.

          "PCA didn't work well" is meaningless. Perhaps the samples clustered by group or perhaps not, but in neither case can one say that the PCA itself didn't work well.

          Comment

          • wbb1813
            Member
            • May 2014
            • 12

            #6
            Thanks for all!I think I have understand the important of biological replicates ,and I will use some magnitude threshold,or some biological methods to find the genes which I interested in.
            On the other hand,I want to get the raw counts about Prostate cancer from TCGA,then use DEseq and edgeR to find differential expression genes,I don't know whether I can get the raw data from TCGA.
            I get a new question ,my 180 sample from TCGA is from different batch ,is there a impact to our analysis ?

            Comment

            • dpryan
              Devon Ryan
              • Jul 2011
              • 3478

              #7
              Yes, batch effects can be quite large on occasion (or quite small, you never know). Have a look at the SVA package on bioconductor.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                by SEQadmin2



                CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                Despite this, “CRISPR helped turn genome editing from a specialized technique into
                ...
                07-31-2026, 11:01 AM
              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Yesterday, 07:41 AM
              0 responses
              12 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 08-03-2026, 10:13 AM
              0 responses
              26 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-31-2026, 02:55 AM
              0 responses
              39 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-24-2026, 12:17 PM
              0 responses
              25 views
              0 reactions
              Last Post SEQadmin2  
              Working...